Shares of French technology company Dassault Systemes (DSY.FR) are trading down today although the financial report turned out to be moderately positive. Management conveyed that the company is on track to meet its annual growth target. The company beat earlier targets in Q2 - the declines can be indirectly linked to profit realization and a slight decline in margins.
The company reaffirmed its target of 8 to 9% revenue growth and earnings per share in the region of €1.18 - €1.20 in 2023. Earnings per share rose 7% y/y with high operating margins above 30%. Free cash flow from operations since the beginning of 2023 was EUR 1.03 billion
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app- Revenues increased by 8%, to €1.45 billion
- Software revenues rose 8%, to €1.31 billion
- License revenues increased 6%, to €278.9 million
- Subscription revenues rose 9%;
- Services revenue rose 7%.a=
North and South America accounted for 40% of the company's revenue (10% year-on-year increase). Results were driven by demand from the aerospace and defense industries. Revenues in Europe grew 9% (36% of software revenues). Management indicated that Germany and France dominated with orders from retailers and transportation. Revenues from Asia achieved 24% y/y growth, driven mainly by rebounding demand in China and India.
Company pointed to strong y/y revenue growth from software business
- IT revenue for industry rose 7% to €686.7 million (52% of software revenue)
- IT revenue for the scientific sector rose 7% y/y to €287.2 million (22% of software revenue).
- IT revenue for government grew 12% to €335.1 million (26% of software revenue)
- Revenue from 3DExperience increased 2% y/y (32% of software revenue)
- Sales in Dassault's cloud computing segment posted double-digit, 11% y/y growth (23% of software revenue)
Dassault pointed to strong growth in orders from the defense and medical sectors. At the same time, however, operating income indicated signs of stagnation (1% y/y growth) at €448.9 million. The operating margin, although very high (31%), fell from 32% in Q2 2023. Operating expenses increased. The company estimates a return to double-digit y/y revenue growth from the medical sector. It highlighted the renewal of key partnerships with the pharmaceutical industry, which is not helped by the slowdown effect after the covid pandemic.
Dassault Systemes (DSY.FR) shares, D1 interval. Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
